Once known as a club drug, MDMA – commonly referred to as Ecstasy or Molly – is being studied as a potential treatment for post-traumatic stress disorder (PTSD).
PTSD is a psychiatric disorder that results from a traumatic experience, like experiencing or witnessing an especially life-threatening, horrifying, or dangerous event.
In addition to combat veterans, there are several other groups (for example, rape victims and emergency responders) who are at higher risk for this condition. PTSD can be characterized by flashbacks to the traumatic event, frightening thoughts, angry outbursts, and exaggerated feelings of guilt or blame, among other symptoms.
According to an article in The Buzz, published by The National Center on Addiction and Substance Abuse (CASA), it is estimated that eight million adult Americans suffer from PTSD. Around 37 percent of all cases of PTSD are considered severe, which means they are typically resistant to traditional therapy and medications, such...
The 9/11 terrorist attacks on the World Trade Center resulted in elevated post-traumatic stress disorder (PTSD) and alcohol use among exposed individuals.
The relationship among traumatic exposure, PTSD, and excessive drinking is well documented; however, little is known about these relationships in the long term. This study examines factors increasing binge drinking risk among exposed individuals a decade post-9/11.
According to an article in American Journal of Preventive Medicine, binge drinking was reported by 24.7% of participants in a research study, of whom 36.9% reported high-intensity binge drinking.
The article concludes that observed associations among traumatic exposure, PTSD, and excessive drinking underscore the need for improved therapies addressing excessive drinking and PTSD concurrently, inclusion of repeated post-event screening for excessive drinking, and evidence-based population-level interventions to reduce alcohol consumption.
The Drug Enforcement Administration (DEA) has given approval for a study that will evaluate the effectiveness of marijuana as a treatment for post-traumatic stress disorder (PTSD), according to The Denver Post.
Researchers plan to enroll 76 veterans at clinics in Phoenix and Baltimore. They will study how well smoking different strains and potencies of marijuana treats PTSD. The marijuana will be supplied by the federal government’s marijuana farm at the University of Mississippi.
Military Times reports it will be the first randomized, controlled research in the United States for PTSD that will use the actual marijuana plant instead of oils or synthesized cannabis.
Some veterans say marijuana eases their PTSD symptoms and has allowed them to stop using prescription medications, but little scientific research supports these claims, the article notes.
“This is a critical step in moving our botanical drug development program forward at the federal level to gather information on...
An increasing number of veterans are treating their post-traumatic stress disorder (PTSD) with marijuana, according to the Associated Press.
Marijuana is not approved by the Department of Veterans Affairs.
Research on marijuana’s effect on PTSD is contradictory and limited, the article notes. Some studies indicate marijuana may help people manage symptoms of PTSD in the short term, while one study suggested it may worsen symptoms.
The Marijuana Policy Project says 10 states have listed PTSD among conditions for which medical marijuana can be prescribed. A few more states allow doctors enough discretion to recommend marijuana to patients suffering from PTSD.
The U.S. Senate passed an amendment in November that would have allowed VA physicians to recommend medical marijuana to veterans in states where it is legal, but the measure failed to pass the House.In order for VA doctors to be able to recommend a drug, federal law requires that randomized, controlled...